Euromedis Groupe SA (61R) Stock Statistics & Valuation Metrics

Euromedis Groupe SA has a market cap or net worth of €11.41M. The enterprise value is €5.23M.

Euromedis Groupe SA has 2,874,883 shares outstanding. The number of shares has decreased by -2.65% in one year.

Euromedis Groupe SA’s return on equity (ROE) is 0.58 and return on invested capital (ROIC) is -15.62%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Euromedis Groupe SA had revenue of 37.43M and earned 13.11M in profits. Earnings per share was 4.60.

In the last 12 months, operating cash flow was 796.00K and capital expenditures -21.00K, giving a free cash flow of 775.00K billion.

Euromedis Groupe SA pays an annual dividend of €0.09, resulting in a dividend yield of ―

Euromedis Groupe SA upcoming earnings date is ―, ―.

Euromedis Groupe SA as a current ratio of 2.58, with Debt / Equity ratio of 48.76%

In the past 12 months, Euromedis Groupe SA has paid 269.05K in taxes.

Euromedis Groupe SA EV to EBITDA ratio is -1.43, with an EV/FCF ratio of 0.00.

Euromedis Groupe SA has €18.66M in cash and marketable securities with €9.04M in debt, giving a net cash position of -€9.63M billion.

Gross margin is 9.20%, with operating margin of -15.31%, and net profit margin of 35.03%.

The average price target for Euromedis Groupe SA is ―, which is 11.43% higher than the current price. The consensus rating is ―